| 000 | 01488 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513214830.0 | ||
| 264 | 0 | _c20000914 | |
| 008 | 200009s 0 0 fre d | ||
| 022 | _a1246-7820 | ||
| 024 | 7 |
_a10.1016/s1246-7820(00)80003-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoatti, J P | |
| 245 | 0 | 0 |
_a[Economic analysis versus the principle of guaranteed safety in blood transfusion]. _h[electronic resource] |
| 260 |
_bTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _cJun 2000 |
||
| 300 |
_a228-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBlood Donors |
| 650 | 0 | 4 |
_aBlood Transfusion _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aEthics, Medical |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 |
_aHepatitis C _xblood |
| 650 | 0 | 4 |
_aHepatitis C Antibodies _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMass Screening _xeconomics |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 650 | 0 | 4 |
_aViremia _xblood |
| 700 | 1 | _aLoubière, S | |
| 700 | 1 | _aRotily, M | |
| 773 | 0 |
_tTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _gvol. 7 _gno. 3 _gp. 228-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1246-7820(00)80003-8 _zAvailable from publisher's website |
| 999 |
_c10868863 _d10868863 |
||